Tradestie Institutional Equity Comparison Engine

EVGN vs FRSX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EVGN Overall Edge

EVGN Captures Institutional Edge (2โ€“0 Pillars ยท 4โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Evogene Ltd. (EVGN) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, EVGN trades at N/M Forward P/E with -858.2% operating margin (-60.7% YoY revenue) versus FRSX at N/M Forward P/E and -2642.2% operating margin (-32.8% YoY). In options structure, EVGN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against FRSX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
EVGN N/M vs FRSX N/M Fwd P/E
Growth & Margin Winner EVGN
Op Margin -858.2% vs -2642.2% ยท YoY -60.7% vs -32.8%
Momentum & Technical Winner EVGN
1Y -71.9% vs -78.2% ยท 52W Pos 9% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
EVGN NASDAQ
Evogene Ltd.
Agricultural Chemicals
$0.34
-13.17% 1D
Market Cap $6.0M
1M Return -7.58%
1Y Return -71.89%
Forward P/E N/M
Unified AI Score
44.1 / 100 HOLD
Tech 42.0 Fund 44.0 Flow 50.0 Mom 60.0
FRSX NASDAQ
Foresight Autonomous Holdings Ltd. American Depositary Shares
Services-Prepackaged Software
$0.47
-5.82% 1D
Market Cap $2.0M
1M Return -41.73%
1Y Return -78.19%
Forward P/E N/M
Unified AI Score
40.4 / 100 SELL
Tech 25.0 Fund 44.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EVGN -71.89% FRSX -78.19% Spread: +6.3 pp (EVGN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
EVGN TTM Op. Margin: -858.2% FRSX TTM Op. Margin: -2642.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EVGN vs FRSX. Trailing 12-month operating profitability (EVGN -858.2% vs FRSX -2642.2%) and valuation multiples (EVGN N/M vs FRSX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EVGN (4) vs FRSX (2)
Institutional Metric EVGN FRSX Criterion Row Winner
Market Capitalization Scale $6.0M $2.0M Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -60.7% -32.8% Higher Growth FRSX
Operating Margin (TTM) Profitability -858.2% -2642.2% Higher Margin EVGN
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -182.8% -205.9% Higher ROE EVGN
52-Week Range Position Momentum 9% ($0โ€“$1) 0% ($0โ€“$3) Stronger Trend EVGN
Beta / 30D Volatility Risk Regime 1.37ฮฒ ยท 138% Vol 1.23ฮฒ ยท 57% Vol Lower Realized Risk FRSX
Unified Institutional Score Composite Signal 44.1 / 100 (HOLD) 40.4 / 100 (SELL) Higher Composite EVGN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EVGN vs FRSX Buy Guide
EVGN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live EVGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FRSX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FRSX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EVGN nor FRSX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.